Castle Biosciences’ Full DecisionDx® Portfolio of Dermatologic Tests to Be Interfaced with EMA® Electronic Health Records System
Interface facilitates ease of ordering within the dermatologic EMR platform FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #DecisionDxMelanoma–Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management decisions and improve patient outcomes, today announced its agreement with ModMed to establish an interface with ModMed’s electronic health records system, EMA®. The interface is designed to enable […]



